GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
CompletedNot applicableNCT03699007
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The broad aim of this study is to implement and evaluate the efficacy of Graded Exposure Treatment (GET Living) to target elevated pain-related fears in children with chronic pain at the Stanford Pediatric Pain Management Clinic (PPMC). The investigators will evaluate the effectiveness and acceptability of this intervention for children with high levels of pain-related fear and functional disability. If proven efficacious, it will allow for the dissemination of this innovative treatment model to others working with children and adolescents with chronic pain.
Study details
- Official title
- GET Living: Graded Exposure Treatment for Children and Adolescents With Chronic Pain
- Conditions
- Pediatric Pain
- Chronic Pain, Widespread
- Musculoskeletal Pain
- Interventions
- Behavioral: Graded Exposure Therapy (GET Living)
- Behavioral: Multidisciplinary Pain Management (MPM)
- Sponsor
- Laura E Simons
- Collaborators
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Organization
- Stanford University
- Start date
- 2019-01-23
- Primary completion
- 2022-01-28
- Sex
- All
- Age range
- from 8 Years to 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 8 - 18 years old; Male or Female * Musculoskeletal pain (e.g. localized \[back, limb\], diffuse) not due to acute trauma (e.g. active sprain or fracture). * Moderate to high pain-related fear ( ≥ 35 on the FOPQ-C) * Moderate to high functional disability ( ≥ 13 on the FDI) * English Language Proficiency Exclusion Criteria: * Significant cognitive impairment (e.g., brain injury) * Significant medical or psychiatric problem that would interfere (e.g., seizures, psychosis, suicidality)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03699007